Literature DB >> 18345519

Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.

Spyridon Marinopoulos1, Lamprini Skorda, Stylianos Karatapanis, Antonis Rasidakis.   

Abstract

A 67-year-old man underwent total resection of the left lung because of adenocarcinoma, with no evidence of extra-thoracic spread of the cancer. On follow-up, metastatic bone disease was documented and chemotherapy (CMT) which included cisplatin, docetaxel, vinorelbine, and topotecan was administered. Six months after completion of CMT, a rise in total serum protein was noted. Bone marrow biopsy revealed the diagnosis of an IgG lambda myeloma. We report a case of a man with adenocarcinoma of the lung who presented multiple myeloma after completion of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18345519     DOI: 10.1007/s12032-008-9056-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

1.  Multiple myeloma and its treatment.

Authors:  Barbara Felder
Journal:  Clin J Oncol Nurs       Date:  2002 Nov-Dec       Impact factor: 1.027

Review 2.  Novel therapies for multiple myeloma.

Authors:  Toshiaki Hayashi; Teru Hideshima; Kenneth C Anderson
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

3.  Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.

Authors:  M J Bargetzi; J Passweg; E Baertschi; A Schoenenberger; C Gwerder; A Tichelli; J Burger; W Mingrone; R Herrmann; A Gratwohl; M Wernli
Journal:  Bone Marrow Transplant       Date:  2003-01       Impact factor: 5.483

Review 4.  Preclinical data with bortezomib in lung cancer.

Authors:  David P Schenkein
Journal:  Clin Lung Cancer       Date:  2005-10       Impact factor: 4.785

5.  Risk of second cancer after chronic lymphocytic leukemia.

Authors:  Claudia Schöllkopf; Ditte Rosendahl; Klaus Rostgaard; Christian Pipper; Henrik Hjalgrim
Journal:  Int J Cancer       Date:  2007-07-01       Impact factor: 7.396

6.  Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.

Authors:  Israel Zighelboim; Sheri Babb; Feng Gao; Matthew A Powell; David G Mutch; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2007-03-01       Impact factor: 5.482

Review 7.  Secondary lung tumors in hematological patients.

Authors:  Dino Amadori; Sonia Ronconi
Journal:  Semin Respir Crit Care Med       Date:  2005-10       Impact factor: 3.119

8.  Second malignancies in patients with multiple myeloma.

Authors:  I P Law; J Blom
Journal:  Oncology       Date:  1977       Impact factor: 2.935

9.  Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

Authors:  Kami Maddocks-Christianson; Susan L Slager; Clive S Zent; Megan Reinalda; Timothy G Call; Thomas M Habermann; Deborah A Bowen; James D Hoyer; Susan Schwager; Diane F Jelinek; Neil E Kay; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2007-11       Impact factor: 6.998

10.  Effect of vinorelbine on the growth of human myeloma cell lines in vitro.

Authors:  Naoya Ochiai; Chihiro Shimazaki; Tohru Inaba; Shin-ichi Fuchida; Akira Okano; Mayumi Hatsuse; Hideyo Hirai; Eishi Ashihara; Naohisa Fujita; Masao Nakagawa
Journal:  Leuk Res       Date:  2002-08       Impact factor: 3.156

View more
  4 in total

1.  Simultaneous Presentation of Multiple Myeloma and Lung Cancer: Case Report and Gene Bioinformatics Analysis.

Authors:  Ping-Ping Xiao; Bing-Qing Luo; Wei Fan; Xu-Yan Chen; Zhi-Gao Dong; Jin-Mei Huang; Yi Zhang; Yong-Quan Chen
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

2.  Simultaneous multiple myeloma and non-small cell lung carcinoma: A case report and review of the literature.

Authors:  Huan-Huan Dong; Jing Li; Lin Kang; Qiang Wei; Yan Li
Journal:  Oncol Lett       Date:  2022-05-03       Impact factor: 3.111

3.  Multiple myeloma emerging after prolonged gefitinib treatment for non-small cell lung carcinoma.

Authors:  Sian Yik Lim; Sachiko Ando; Kaoru Nishiyama; Simi Padival
Journal:  Case Rep Oncol       Date:  2011-04-06

4.  A case report of secondary synchronous diagnosis of multiple myeloma and systemic lupus erythematosus after breast cancer treatment: A CARE-compliant article.

Authors:  Pei-Hsin Chen; Heng-Hsin Tung; Chin-Husan Lin; Kuan-Po Huang; Yung-Lun Ni; Chin-Yao Lin
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.